Cargando…

Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis

OBJECTIVE: To investigate the effect of plasma homocysteine (Hcy) and C-reactive protein (CRP) levels in patients with craniocerebral injury. METHODS: A retrospective analysis of data from patients with craniocerebral injury who underwent surgery. Patients were stratified according to the extent of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenjia, Qin, Zhongqiao, Xian, Kecong, Tang, Shuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607269/
https://www.ncbi.nlm.nih.gov/pubmed/31852292
http://dx.doi.org/10.1177/0300060519882202
_version_ 1783604614248005632
author Zhang, Wenjia
Qin, Zhongqiao
Xian, Kecong
Tang, Shuhong
author_facet Zhang, Wenjia
Qin, Zhongqiao
Xian, Kecong
Tang, Shuhong
author_sort Zhang, Wenjia
collection PubMed
description OBJECTIVE: To investigate the effect of plasma homocysteine (Hcy) and C-reactive protein (CRP) levels in patients with craniocerebral injury. METHODS: A retrospective analysis of data from patients with craniocerebral injury who underwent surgery. Patients were stratified according to the extent of the craniocerebral injury into severe, moderate and mild craniocerebral injury groups. Serum Hcy and CRP levels were determined at admission, at 7 days after treatment and at 3 months after injury. Univariate and multivariate Cox regression analyses were undertaken to identify prognostic factors. RESULTS: The study enrolled 96 patients: 29 patients with mild injury; 33 patients with moderate injury; and 34 patients with severe injury. Serum Hcy and CRP levels at admission were significantly higher in the severe craniocerebral injury group than in the other two groups; and they were significantly higher the moderate craniocerebral injury group compared with the mild craniocerebral injury group. Serum Hcy and CRP levels of the three groups of patients were significantly lower after 7 days of treatment than those before treatment. The levels of Hcy and CRP were positively correlated in all three groups. CONCLUSION: Serum Hcy and CRP levels in patients could be used to monitor the condition and prognosis of patients with craniocerebral injury.
format Online
Article
Text
id pubmed-7607269
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-76072692020-11-13 Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis Zhang, Wenjia Qin, Zhongqiao Xian, Kecong Tang, Shuhong J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To investigate the effect of plasma homocysteine (Hcy) and C-reactive protein (CRP) levels in patients with craniocerebral injury. METHODS: A retrospective analysis of data from patients with craniocerebral injury who underwent surgery. Patients were stratified according to the extent of the craniocerebral injury into severe, moderate and mild craniocerebral injury groups. Serum Hcy and CRP levels were determined at admission, at 7 days after treatment and at 3 months after injury. Univariate and multivariate Cox regression analyses were undertaken to identify prognostic factors. RESULTS: The study enrolled 96 patients: 29 patients with mild injury; 33 patients with moderate injury; and 34 patients with severe injury. Serum Hcy and CRP levels at admission were significantly higher in the severe craniocerebral injury group than in the other two groups; and they were significantly higher the moderate craniocerebral injury group compared with the mild craniocerebral injury group. Serum Hcy and CRP levels of the three groups of patients were significantly lower after 7 days of treatment than those before treatment. The levels of Hcy and CRP were positively correlated in all three groups. CONCLUSION: Serum Hcy and CRP levels in patients could be used to monitor the condition and prognosis of patients with craniocerebral injury. SAGE Publications 2019-12-18 /pmc/articles/PMC7607269/ /pubmed/31852292 http://dx.doi.org/10.1177/0300060519882202 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Zhang, Wenjia
Qin, Zhongqiao
Xian, Kecong
Tang, Shuhong
Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title_full Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title_fullStr Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title_full_unstemmed Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title_short Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
title_sort assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607269/
https://www.ncbi.nlm.nih.gov/pubmed/31852292
http://dx.doi.org/10.1177/0300060519882202
work_keys_str_mv AT zhangwenjia assessmentofplasmahomocysteinelevelsinpatientswithcraniocerebralinjuryandprognosis
AT qinzhongqiao assessmentofplasmahomocysteinelevelsinpatientswithcraniocerebralinjuryandprognosis
AT xiankecong assessmentofplasmahomocysteinelevelsinpatientswithcraniocerebralinjuryandprognosis
AT tangshuhong assessmentofplasmahomocysteinelevelsinpatientswithcraniocerebralinjuryandprognosis